- Visibility 189 Views
- Downloads 44 Downloads
- Permissions
- DOI 10.18231/j.ijcbr.2020.086
-
CrossMark
- Citation
Prevalence of atherogenic dyslipidemia in young asymptomatic medical professionals of a Tertiary Care Hospital in South India: A cross-sectional study
- Author Details:
-
R Amirtha Jansi Rani *
-
P Deepa
-
R Shanthi
Abstract
Atherogenic dyslipidemia is a condition characterised by an elevation of triglycerides and small-dense low-density lipoprotein (sdLDL) and a reduction in high-density lipoprotein cholesterol (HDL Cholestrol). Prevalence studies from India is less and are of small scale in nature. There are no studies among medical and paramedical professionals that document the prevalence of dyslipidemia in India. In order to determine the prevalence of dyslipidemia in young asymptomatic medical and paramedical professionals, the following study was done with lipid profile and with Atherogenic Index of plasma (AIP), Castelli’s Risk Ratio I&II (CRR I&II). From May 2016 to August 2016, a cross-sectional study was done among medical and paramedical professionals (N=120) aged between 18-40 years working in a tertiary care hospital. Fasting and post prandial blood sugar, total cholesterol, triglycerides, high density lipoprotein, low density lipoprotein, atherogenic ratios and BMI were calculated. Among the 120 participants (80 doctors; 40 nurses), 43(35.8%) were males and 77(64.1%) were females. Out of 120 participants, 79 (65.8%) had BMI within the normal range, 37 (30.8%) had BMI 25-30 and 4 (3.4%) of them had BMI 30-35. Atherogenic dyslipidemia is a potent marker of coronary artery disease risk, especially among asymptomatic young individuals. Indices for coronary risk assessment are more potent than lipid profile. They can be used as effective screening tool in clinical settings and epidemiological studies. Young individuals engaged in white collar jobs must be screened for atherogenic dyslipidemia from an early age to prevent coronary artery disease.
Introduction
Atherogenic dyslipidemia is a condition characterised by an elevation of triglycerides and small-dense low-density lipoprotein (sdLDL) and a reduction in high-density lipoprotein cholesterol (HDL Cholestrol).[1] The term dyslipidemia differs from hyperlipidaemia, in that dyslipidemia refers to the derangement of one or more lipoproteins like elevated total cholesterol, LDL-cholesterol and triglycerides, or lowering of HDL cholesterol as per National Cholesterol Education Program Adult Treatment Plan III (NCEP ATP III), whereas mere elevation of lipoproteins is labelled as ‘hyperlipidaemia’.[2], [3], [4] Dyslipidemia may result from either over-production or lack of clearance of the lipoprotein particles in plasma, or may be related to defects in the apolipoprotein metabolism due to metabolic pathway enzyme deficiencies. It is a proven risk factor in cardiovascular diseases.[5], [6] Dyslipidemia has been identified as one of the most important risk factor for CAD (Coronary Artery Disease) by the INTERHEART- South Asia study.[7]
Prevalence studies from Heart SCORE and India SCORE shows there are population variations in Atherogenic dyslipidemia with an increased prevalence of small-dense LDL and TG/HDL ratio>3 among Asian Indians.[8] Review studies in India show a prevalence of dyslipidemia between 10 to 73%.[4] Urban professionals with sedentary lifestyle had higher prevalence. [9] Less physical activity and high carbohydrate diet with low polyunsatrated fatty acid (PUFA) is attributed to this.[8], [10] Prevalence studies from India is less and are of small scale in nature. There are no studies among medical and paramedical professionals that documents the prevalence of dyslipidemia in India.
In order to determine the prevalence of dyslipidemia in young asymptomatic medical and paramedical professionals, the following study was done with lipid profile and with Atherogenic Index of plasma (AIP), Castelli’s Risk Ratio I&II (CRR I&II).
Materials and Methods
From May 2016 to August 2016, a cross-sectional study was done among medical and paramedical professionals (N=120) aged between 18-40 years working in a tertiary care hospital to study the prevalence of dyslipidemia among young asymptomatic medical and paramedical professionals. Institutional ethics committee approval was obtained and participants were recruited for the study after obtaining written informed consent. Individuals having Diabetes, Hypertension, Dyslipidemia, smoking, alcoholism Hypothyroidism, any chronic illness, and treatment for any metabolic disorders were excluded. Anthropometric readings like height, weight Body Mass index (BMI) and Waist/Hip ratio were calculated based on WHO classification and Dr. Chadha’s anthropometric correlation study.[11]
Blood collection was done under universal aseptic precautions, after an overnight fast for 8-12 hours. About 5ml of blood was drawn from the ante-cubital vein and transferred into red topped serum tubes. The blood samples were analysed on the same day within few hours of blood collection.
The biochemical parameters relevant to the study were analysed by the following methodologies.
Investigations
Fasting and post prandial blood sugar
Blood glucose estimated using GOD-POD principle in random access fully automated chemistry analyzer.
Total cholesterol
Total cholesterol was done in fasting serum sample using enzymatic method in fully automated chemistry analyzer.
Triglycerides
Enzymatic method was used for estimating Triglycerides.
High density lipoprotein
Estimated by Direct (homogenous) measurement method in random access fully automated chemistry analyzer.
Low density lLipoprotein
Calculated using Friedwald’s formula.
Atherogenic ratios calculation
Atherogenic Index of Plasma (AIP) = log TG/HDLc.
Definitions and preferred cut-off values
For serum lipids, we referred to NCEP - ATP III Guidelines. According to these standard guidelines, hypercholesterolemia is defined as TC >200mg/dL, LDL-C as >100mg/dL, hypertriglyceridemia as TG>150mg/dL and HDL-C <40mg/dL. Dyslipidemia is defined as the presence of one or more than one abnormal serum lipid concentration. For serum Glucose levels, we referred to ADA Guidelines. Persons with fasting blood glucose >126mg/dl or who were on medication for diabetes was considered as having diabetes mellitus.[2], [12] BMI cut-off of 18.5-24.9 was taken as normal. AIP risk cut-off is low risk <0.1, medium risk 0.1 – 0.24 and high risk >0.24. The Atherogenic Indices of the study population namely AIP, CRR I & II has been categorized as per Misra et al.[4]
Results
This study included 80 doctors and 40 nurses. Fasting and post prandial blood glucose was performed and diabetes was ruled out for all participants before commencement of the study. Among the 120 participants, 43(35.8%) were males and 77(64.1%) were females. Out of 120 participants, 79 (65.8%) had BMI within the normal range, 37 (30.8%) had BMI 25-30 and 4 (3.4%) of them had BMI 30-35. [Table 1] shows the distribution of dyslipidemia among the participants. [Table 2] shows the prevalence of atherogenic risk based on coronary risk indices. Around 51.6% (n=62) of participants had Waist/Hip (W/H) ratio >0.9, in which males were 34.1% (n=41) and females were 17.5% (n=21). W/H ratio was noted to be higher in males than females. Lipid profile reveals only the presence of dyslipidemic changes, but atherogenic dyslipidemic changes are predicted by better sensitive indices like AIP, CRR I &II.
S.No | Type of Dyslipidemia | Prevalence Percentage | No. of Individuals |
1. | Hypercholesterolemia | 5% | 6 |
2. | Hypertriglyceridemia | 10.8% | 12 |
3. | High LDL-cholesterol | 36.6% | 44 |
4. | Low HDL-cholesterol | 50.8% | 60 |
Index | Risk Stratification | ||
AIP (LogTGL/HDL) | Low Risk (<0.1) | Medium Risk (0.1-0.24) | High Risk (>0.24) |
4 (3.3%) | 20 (16.6%) | 96 (80%) | |
CRR I (TC/HDL) | Low Risk | High Risk | |
69 (57.5%) | 51 (42.5%) | ||
CRR II (LDH/HDL) | Low Risk | High Risk | |
104 (86.6%) | 16 (13.3%) |
Discussion
Non-communicable diseases are gradually increasing among Indians.[13] There has been an increased morbidity and mortality due to non-communicable diseases in India.[14] Coronary artery disease constitutes the majority of the mortality and morbidity of these non-communicable diseases.[15], [16] A number of risk factors either directly or indirectly leads to the origin, development and progression of coronary artery disease.[17], [18], [19] These risk factors differ between age groups, socioeconomic status and nature of job.[20] Therefore, the risk of having coronary artery disease in one’s life time can be predicted using these factors.[21], [22] Dyslipidemia is a significant predictor of coronary artery disease in asymptomatic healthy individuals.[2], [23] Scientific evidences prove the strong association between incidence of CAD with atherogenic dyslipidemia (high level of LDL-c and low level of HDL-c).[24], [25]
Dyslipidemia may result from either over-production or lack of clearance of the lipoprotein particles in plasma, or may be related to defects in the apolipoprotein metabolism due to metabolic pathway enzyme deficiencies. Dyslipidemia is of two types; primary- due to genetic defects which are non-modifiable and not treatable, secondary - which are modifiable and treatable. Atherogenic lipoprotein phenotype is a dyslipidemic pattern which consists of hypertriglyceridemia, increased small-dense LDL particles, and low HDL-cholesterol levels. Very low density lipoprotein (VLDL) on its metabolic journey, exchanges triglycerides for cholesterol ester with LDL by the action of the enzyme cholesterol ester transfer protein (CETP), and the LDL becomes triglyceride rich lipoprotein. Further, the triglyceride in LDL is hydrolysed by lipoprotein lipase or hepatic lipase resulting in a smaller denser LDL (Sd LDL-C) particle. Thus, increased VLDL secretion results in increased generation of small-dense LDL particles, particularly when serum triglyceride concentrations are >1.5 mmol/L (132.85 mg/dL).[26], [27], [28] High levels of small dense LDL promote atherogenesis by the following mechanisms: a) rapid infiltration into the arterial wall than the normal-sized LDL b) increased susceptibility to retention in the extracellular matrix and c) increased oxidation.[5], [29] Low levels of HDL cholesterol are often caused by the core lipid exchange, as well as accelerated clearance of HDL particles, which explains the frequent combined occurrence of hypertriglyceridemia and low HDL-cholesterol levels. Individuals with abnormal fat distribution, characterized by a high waist-to-hip ratio or high truncal subcutaneous fat are predisposed to develop insulin resistance and dyslipidemia.[30], [31] This body composition is commonly seen in Asian Indians.[32], [33], [34], [35] Patients with upper trunk obesity were found to have higher levels of non-esterified fatty acids (NEFAs) than patients with lower body obesity. This excess NEFA leads to hepatic steatosis and increased VLDL output from liver, thereby increasing the concentration of small-dense LDL and reduced HDL-c.[4]
Prevalence studies on atherogenic dyslipidemia are very less in India. In this study, the prevalence was higher than the previous studies. Female participants were more than males and the dyslipidemic changes with coronary risk were also observed more in females than in males. BMI being a good indicator of total body adiposity reflects the underlying dyslipidemic changes as explained early. In this study, 41 (34.8%) participants were with BMI> 25, most of them were females. Inadequate physical activities among the medical professionals, in addition to obese ethnicity in young Indian women, could be the probable explanation for the higher prevalence of obesity in this study population. Intake of calorie rich diet and lack of exercise as a part of modern lifestyle causes truncal adiposity and highly predisposes to dyslipidemia and insulin resistance. Waist to Hip (W/H) circumference ratio is a better indicator of central obesity than BMI. The cut off was taken as 0.9 from Dr. D S Chadha et al study on anthropometry. In the present study, 51.6% (62) of participants had W/H ratio >0.9, in which males were 34.1% (41) and females were 17.5% (21).[11] W/H ratio was noted to be higher in males than females. Fasting and post prandial blood glucose was performed and the diabetes was ruled out for all participants before commencement of the study.
Dyslipidemia observed with fasting lipid profile for all the participants were measured. A combined lipid derangement was observed in most of the individuals but not in all four parameters in the same person (TC, TGL, LDL-c & HDL-c). Hypercholesterolemia was noted only for six participants while hypertriglyceridemia and low HDL-c was found to be higher in females. Hypertriglyceridemia with low HDL-c has twofold increased risk of CAD which was observed in this study population.[36] As explained earlier, adiposity leading to increased VLDL output from the liver and rapid core lipid exchange could be the justified cause for combined hypertriglyceridemia and low HDL-c.
The Framingham heart study over years, has established the role of deranged lipid profile in the progression of CAD and correcting the LDL-c levels as the primary target for treatment. It is not the serum lipid profile alone that rules out the coronary artery disease, atherogenic dyslipidemia should be estimated and sensitive indices for coronary risk assessment like Atherogenic Index of Plasma, Castelle’s Risk Ratio I & II should be calculated. This includes Total Cholesterol, LDL-c, HDL-c and their ratios which in turn are individual risk predictors.[37], [38], [39] In this study, AIP index showed that 3.3% (n=4) had low risk, 16.6% (n=20) had medium risk and 80% (n=96) had high risk for CAD. This is similar to the published literature.[40] Out of 120 participants, 42.5% (n=51) and 13.3% (n=16) had high risk for CRR-I and CRR-II respectively. The present study and the reference study emphasises that, it is the ratio of bad cholesterol to good cholesterol that predicts the coronary artery disease risk rather than the lipid profile alone in an individual. Taking the ratios alone into consideration, the risk of developing coronary artery disease is in high percentage among young medical and paramedical professionals than the expected level.
Conclusion
Atherogenic dyslipidemia is a potent marker of coronary artery disease risk, especially among asymptomatic young individuals. Indices for coronary risk assessment like Atherogenic Index of Plasma, Castelle’s Risk Ratio I & II are more potent and can be used as effective screening tool in clinical settings and epidemiological studies. Young individuals engaged in white collar jobs must be considered for regular screening from an early age to prevent coronary artery disease. Future studies should focus on replicating the present study at a larger scale.
Source of Funding
None.
Conflict of Interest
None.
References
- Austin MA, King MC, Vranizan KM, Krauss RM. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.. Circ. 1990;82(2):495-506. [Google Scholar]
- . Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). J Am Med Assoc. 2001;285(19):2486-97. [Google Scholar]
- . Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circ. 2002;106(25). [Google Scholar]
- Misra A, Luthra K, Vikram NK. Dyslipidemia in Asian Indians: Determinants and significance. J Assoc Physicians India. 2004;52:137-42. [Google Scholar]
- Grundy SM. Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome. Am J Cardiol. 1998;81(4):18-25. [Google Scholar]
- Musunuru K. Atherogenic Dyslipidemia: Cardiovascular Risk and Dietary Intervention. Lipids. 2010;45(10):907-14. [Google Scholar]
- Yusuf PS, Hawken S, Ôunpuu S, Dans T, Avezum A, Lanas F. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet. 2004;364:937-52. [Google Scholar]
- Mulukutla SR, Venkitachalam L, Marroquin OC, Kip KE, Aiyer A, Edmundowicz D. Population variations in atherogenic dyslipidemia: A report from the HeartSCORE and IndiaSCORE Studies. J Clin Lipidol. 2008;2(6):410-7. [Google Scholar]
- Joshi SR, Anjana RM, Deepa M, Pradeepa R, Bhansali A, Dhandania VK. Prevalence of dyslipidemia in urban and rural India: The ICMR-INDIAB study. PLoS One. 2014;9(5). [Google Scholar]
- Ramachandran A, Snehalatha C, Satyavani K, Sivasankari S, Vijay V. Metabolic syndrome in urban Asian Indian adults—a population study using modified ATP III criteria. Diabetes Res Clin Pract. 2003;60(3):199-204. [Google Scholar]
- Cdr W, Chadha DS, Singh G, Capt G, Kharbanda P, Vasdev V. Anthropometric correlation of lipid profile in healthy aviators. Ind J Aerosp Med. 2006. [Google Scholar]
- . Diagnosis and classification of diabetes mellitus. Diabetes Care. 2009;32(1):62-7. [Google Scholar]
- Ghaffar A, Reddy KS, Singhi M. Burden of non-communicable diseases in South Asia. Br Med J. 2004;328(7443):807-10. [Google Scholar]
- Upadhyay RP. An overview of the burden of non-communicable diseases in India. Iran J Public Health. 2012;41(3):1-8. [Google Scholar]
- Gupta R, Joshi P, Mohan V, Reddy KS, Yusuf S. Epidemiology and causation of coronary heart disease and stroke in India. Heart. 2008;94(1):16-26. [Google Scholar]
- Gupta R, Gupta VP, Sarna M, Bhatnagar S, Thanvi J, Sharma V. Prevalence of coronary heart disease and risk factors in an urban Indian population: Jaipur heart watch-2. Indian Heart J. 2002;54(1):59-66. [Google Scholar]
- Yarnell J, Yu S, McCrum E, Arveiler D, Hass B, Dallongeville J. Education, socioeconomic and lifestyle factors, and risk of coronary heart disease: the PRIME Study. Int J Epidemiol. 2005;34(2):268-75. [Google Scholar]
- Kannel WB. Factors of Risk in the Development of Coronary Heart Disease—Six-Year Follow-up Experience. Annals of Internal Medicine. 1961;55(1). [Google Scholar]
- Willeit P, Thompson A, Aspelund T, Rumley A, Eiriksdottir G, Lowe G. Hemostatic Factors and Risk of Coronary Heart Disease in General Populations: New Prospective Study and Updated Meta-Analyses. PLoS ONE. 2013;8(2). [Google Scholar]
- Nourjah P, Wagener DK, Eberhardt M, Horowitz AM. Knowledge of Risk Factors and Risk Behaviors Related to Coronary Heart Disease among Blue and White Collar Males. J Public Health Policy. 1994;15(4). [Google Scholar]
- Chambless LE, Folsom AR, Sharrett AR, Sorlie P, Couper D, Szklo M. Coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC) study. J Clin Epidemiol. 2003;56(9):880-90. [Google Scholar]
- Mcclelland RL, Jorgensen NW, Budoff M, Blaha MJ, Post WS, Kronmal RA. 10-Year Coronary Heart Disease Risk Prediction Using Coronary Artery Calcium and Traditional Risk Factors Derivation in the MESA (Multi-Ethnic Study of Atherosclerosis) with Validation in the HNR (Heinz Nixdorf Recall) Study and the DHS (Dallas Heart Study). J Am Coll Cardiol. 2015;66(15):1643-53. [Google Scholar]
- Kanthe PS, Patil BS, Bagali S, Deshpande A, Shaikh GB, Aithala M. Atherogenic index as a predictor of cardiovascular risk among women with different grades of obesity. Int J Collab Res Intern Med Public Heal. 2012;4(10):1767-74. [Google Scholar]
- Nwagha U, Ikekpeazu EJ, Ejezie FE, Neboh EE, Maduka IC. Atherogenic index of plasma as useful predictor of cardiovascular risk among postmenopausal women in Enugu. Afr Health Sci. 2010;10(3):248-52. [Google Scholar]
- Igweh JC, Nwagha IU, Okaro JM. The effects of menopause on the serum lipid profile of normal females of South East Nigeria. Niger J Physiol Sci. 2005;20(1-2):48-53. [Google Scholar]
- Griffin BA, Freeman DJ, Tait GW, Thomson J, Caslake MJ, Packard CJ. Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk. Atheroscler. 1994;106(2):241-53. [Google Scholar]
- Griffin BA, Minihane AM, Furlonger N, Chapman C, Murphy M, Williams D. Inter relationships between small, dense low-density lipoprotein (LDL), plasma triacylglycerol and LDL apoprotein B in an atherogenic lipoprotein phenotype in free-living subjects. Clin Sci. 1999;97(3):269-76. [Google Scholar]
- Sattar N, Greer IA, Louden J, Lindsay G, McConnell M, Shepherd J. Lipoprotein Subfraction Changes in Normal Pregnancy: Threshold Effect of Plasma Triglyceride on Appearance of Small, Dense Low Density Lipoprotein1. . J Clin Endocrinol Metab. 1997;82(8):2483-91. [Google Scholar]
- Graaf Jd, Hak-Lemmers HL, Hectors MP, Demacker PN, Hendriks JC, Stalenhoef AF. Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects.. Arterioscler Thromb. 1991;11(2):298-306. [Google Scholar]
- Misra A, Garg A, Abate N, Peshock RM, Stray-Gundersen J, Grundy SM. Relationship of anterior and posterior subcutaneous abdominal fat to insulin sensitivity in nondiabetic men. Obes Res. 1997;5(2):93-9. [Google Scholar]
- Misra A, Vikram NK. Clinical and pathophysiological consequences of abdominal adiposity and abdominal adipose tissue depots. Nutr. 2003;19(5):457-66. [Google Scholar]
- Misra A. Body composition and the metabolic syndrome in Asian Indians: A saga of multiple adversities. Natl Med J India. 2003;16(1):3-7. [Google Scholar]
- Misra A. Impact of ethnicity on body fat patterning in Asian Indians and blacks: Relation with insulin resistance. Nutr. 2003;19(9):815-6. [Google Scholar]
- Misra A. Revisions of cutoffs of body mass index to define overweight and obesity are needed for the Asian-ethnic groups. Int J Obes. 2003;27(11):1294-6. [Google Scholar]
- Misra A, Athiko D, Sharma R, Pandey RM, Khanna N. Non-obese hyperlipidemic Asian northern Indian males have adverse anthropometric profile. Nutr Metab Cardiovasc Dis. 2002;12(4):178-83. [Google Scholar]
- Jeppesen J, Hein HO, Suadicani P, Gyntelberg F. Relation of High TG–Low HDL Cholesterol and LDL Cholesterol to the Incidence of Ischemic Heart Disease. Arterioscler Thromb Vasc Biol. 1997;17(6):1114-20. [Google Scholar]
- Dobiášová M. Atherogenic index of plasma [log(triglycerides/HDL-cholesterol)]: Theoretical and practical implications. Clin Chem. 2004;50(7):1113-5. [Google Scholar]
- Stampfer MJ, Sacks FM, Salvini S, Willett WC, Hennekens CH. A Prospective Study of Cholesterol, Apolipoproteins, and the Risk of Myocardial Infarction. New Engl J Med. 1991;325(6):373-81. [Google Scholar]
- Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis. A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein (a), and standard cholesterol screening as predictors of peripheral arterial disease. ACC Curr J Rev. 2001;10(5):25-26. [Google Scholar]
- Niroumand S, Khajedaluee M, Khadem-Rezaiyan M, Abrishami M, Juya M, Khodaee G. Atherogenic Index of Plasma (AIP): A marker of cardiovascular disease. Med J Islam Repub Iran. 2015;29. [Google Scholar]
- Abstract
- Introduction
- Materials and Methods
- Investigations
- Fasting and post prandial blood sugar
- Total cholesterol
- Triglycerides
- High density lipoprotein
- Low density lLipoprotein
- Atherogenic ratios calculation
- Definitions and preferred cut-off values
- Results
- Discussion
- Conclusion
- Source of Funding
- Conflict of Interest
- References
How to Cite This Article
Vancouver
Rani RAJ, Deepa P, Shanthi R. Prevalence of atherogenic dyslipidemia in young asymptomatic medical professionals of a Tertiary Care Hospital in South India: A cross-sectional study [Internet]. Int J Clin Biochem Res. 2020 [cited 2025 Oct 10];7(3):403-407. Available from: https://doi.org/10.18231/j.ijcbr.2020.086
APA
Rani, R. A. J., Deepa, P., Shanthi, R. (2020). Prevalence of atherogenic dyslipidemia in young asymptomatic medical professionals of a Tertiary Care Hospital in South India: A cross-sectional study. Int J Clin Biochem Res, 7(3), 403-407. https://doi.org/10.18231/j.ijcbr.2020.086
MLA
Rani, R Amirtha Jansi, Deepa, P, Shanthi, R. "Prevalence of atherogenic dyslipidemia in young asymptomatic medical professionals of a Tertiary Care Hospital in South India: A cross-sectional study." Int J Clin Biochem Res, vol. 7, no. 3, 2020, pp. 403-407. https://doi.org/10.18231/j.ijcbr.2020.086
Chicago
Rani, R. A. J., Deepa, P., Shanthi, R.. "Prevalence of atherogenic dyslipidemia in young asymptomatic medical professionals of a Tertiary Care Hospital in South India: A cross-sectional study." Int J Clin Biochem Res 7, no. 3 (2020): 403-407. https://doi.org/10.18231/j.ijcbr.2020.086